Sandra J. Horning's Insider Trades & SAST Disclosures
Sandra J. Horning's most recent trade in Revolution Medicines Inc was a trade of 16,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sandra J. Horning.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 10,248 | 10,248 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 95,287 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,945 | 93,432 (0%) | 0% | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 7,801 | - | - | Restricted Stock Unit | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 5,668 | 5,668 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 979 | 979 | - | - | Restricted Stock Units | |
| Olema Pharmaceuticals Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 6,134 | 6,134 | - | - | Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 3,631 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 670 | 1,373 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 670 | 0 | - | - | Restricted Stock Units | |
| EQRx Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 565 | 107,929 | - | - | Earn-out Shares | |
| EQRx Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 101,010 | 101,010 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 5,491 | - | - | Restricted Stock Unit | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 1,112 | 1,744 (0%) | 0% | - | Common Stock | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 1,112 | 3,047 | - | - | Restricted Stock Unit | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 4,061 | 4,061 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 703 | 703 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 703 | 0 | - | - | Restricted Stock Units | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 670 | 670 | - | - | Restricted Stock Units | |
| EQRx Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 470,250 | 470,250 | - | - | Common Stock | |
| EQRx Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 313,500 | 313,500 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 107,364 | 107,364 | - | - | Earn-out Shares | |
| Olema Pharmaceuticals Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 14,665 | 14,665 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 2,223 | 4,159 | - | - | Restricted Stock Unit | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 4,081 | 4,081 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 703 | 703 | - | - | Restricted Stock Units | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 632 | 1,936 | - | - | Restricted Stock Unit | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 632 | 632 (0%) | 0% | - | Common Stock | |
| Olema Pharmaceuticals Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2020 | 86,083 | 86,083 | - | - | Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 7,886 | 7,886 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 1,936 | 2,568 | - | - | Restricted Stock Unit | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2020 | 18,270 | 18,270 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2020 | 17,195 | 17,195 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges